Search

everythinglearnresearchcommunity

for

Search:↓

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

Disrupting Bcl-xL in mice reduces skin cancer risk.

Cells from a skin condition can create new hair follicles and similar growths in mice, and a specific treatment can reduce these effects.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Stat3 affects skin cancer development by altering keratinocyte stem cell behavior.

Activating β-catenin and inactivating PTEN cause follicular tumors, not papillomas, similar to those in Cowden’s Disease.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

UVB exposure affects retinoid metabolism, which is important for skin cancer progression and treatment.

Two patients with lupus had an unusual type of hair loss not typical for the disease.

Soy isoflavones can protect lung tissue from damage during radiation therapy for lung cancer.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

A rare scalp tumor was removed from a 49-year-old woman, with a good outlook if benign but needing careful monitoring if malignant.

Current SLE classifications need refinement, and the complement system is a key therapeutic target.

ABCG2 protein marks stem-like skin cells in human epidermis.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Insurers opposed ASCO's recommendation for a single cancer care pathway program.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.